Today: 18 January 2026
Subscribe
Browse Category

Stock Market News 1 December 2025

Nike (NKE) Stock on December 1, 2025: Ex‑Dividend Drop, Wall Street Targets, and 2026 Outlook

Nike (NKE) Stock on December 1, 2025: Ex‑Dividend Drop, Wall Street Targets, and 2026 Outlook

Nike, Inc. (NYSE: NKE) entered December 2025 at a critical crossroads: the stock is trading ex‑dividend, remains far below its all‑time highs, yet still carries one of the strongest brands in global sport and a broadly bullish Wall Street consensus. As of the afternoon of December 1, 2025, Nike shares trade around $65–66, up roughly 1–2% on the day, with…
1 December 2025
····
Opendoor Technologies (OPEN) Stock in December 2025: Meme Rally, Warrant Dividend and AI Pivot – What Investors Need to Know

Opendoor Technologies (OPEN) Stock in December 2025: Meme Rally, Warrant Dividend and AI Pivot – What Investors Need to Know

Opendoor Technologies Inc. (NASDAQ: OPEN) has turned into one of 2025’s wildest stories on Wall Street. Once a penny stock trading around $0.50, it’s now hovering a little above $7 per share, powered by a meme‑style rally, an aggressive new leadership team, and a high‑stakes pivot toward software and AI. Finviz As of the close on December 1, 2025, Opendoor…
1 December 2025
···
Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences (EXAS) Stock: Abbott’s $23 Billion Deal, Q3 Earnings Beat and What Investors Should Watch Now

Exact Sciences Corporation (NASDAQ: EXAS) has turned into one of the most closely watched healthcare stocks heading into December 2025, thanks to a blockbuster takeover agreement with Abbott Laboratories, strong Q3 results, and a rapid share‑price rally that has pushed EXAS to all‑time highs. As of mid‑day on December 1, 2025, the stock trades around $101 per share, just below…
1 December 2025
····
Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

Q32 Bio (QTTB) Stock Explodes After $592 Million Akebia Deal – Latest News, Analyst Targets and 2027 Outlook

On December 1, 2025, Q32 Bio Inc. (NASDAQ: QTTB) suddenly became one of the most-watched small-cap biotech stocks on Wall Street. Shares of Q32 Bio surged intraday by roughly 90%–170% at various points in Monday’s session, with trading volume soaring from a typical few hundred thousand shares to tens or even hundreds of millions, after the company announced a major…
1 December 2025
····
Coupang (CPNG) Stock Tumbles After Record Data Breach – December 2025 Outlook for Investors

Coupang (CPNG) Stock Tumbles After Record Data Breach – December 2025 Outlook for Investors

Coupang, Inc. (NYSE: CPNG) – often called the “Amazon of South Korea” – is under intense pressure on 1 December 2025 after revealing one of the country’s worst data breaches in more than a decade. The incident has triggered a sharp sell‑off in Coupang’s U.S.-listed shares, even as the company’s underlying business continues to post strong revenue growth and rising…
1 December 2025
···
Danaher (DHR) Stock on December 1, 2025: Q3 Beat, Legal Probes and Fresh Price Targets – Is the Premium Still Worth Paying?

Danaher (DHR) Stock on December 1, 2025: Q3 Beat, Legal Probes and Fresh Price Targets – Is the Premium Still Worth Paying?

Danaher Corporation (NYSE: DHR) enters December 2025 trading around the mid‑$220s per share, a high‑quality life‑sciences and diagnostics name that continues to command a premium valuation — and attract both bullish analysts and governance‑focused law firms. TS2 Below is a detailed, news‑driven overview of Danaher’s latest stock performance, legal and institutional developments, analyst forecasts and key themes to watch into…
1 December 2025
····
PepsiCo (PEP) Stock Today: Price, Dividend, Analyst Forecasts and Key News on December 1, 2025

PepsiCo (PEP) Stock Today: Price, Dividend, Analyst Forecasts and Key News on December 1, 2025

Updated: December 1, 2025 PepsiCo, Inc. (NASDAQ: PEP) remains one of Wall Street’s classic “defensive” stocks, but 2025 has turned into a transition year marked by slower growth, activist pressure, tariff headwinds and shifting consumer tastes. At the same time, the company is leaning on aggressive cost cuts, a rich dividend, and new efficiency targets to rebuild investor confidence. Below…
1 December 2025
····
Mondelez International (MDLZ) Stock Today: Price, Latest News, Dividend and Forecast to 2030

Mondelez International (MDLZ) Stock Today: Price, Latest News, Dividend and Forecast to 2030

Mondelez International, Inc. (NASDAQ: MDLZ), the maker of Oreo, Cadbury, Toblerone and Ritz, is back in focus on December 1, 2025 after a year of guidance cuts, cocoa-driven margin pressure and fresh questions about demand — but also growing evidence the stock may now be undervalued. Below is a structured rundown of today’s price action, the newest headlines, Wall Street…
1 December 2025
····
GE Aerospace Stock on December 1, 2025: Price, Fresh News, and 2026 Forecasts

GE Aerospace Stock on December 1, 2025: Price, Fresh News, and 2026 Forecasts

As of late trading on December 1, 2025, GE Aerospace (NYSE: GE) is changing hands at about $290.58 per share, down roughly 2.6% on the day and around 8% below its all‑time high near $316.67. Even after today’s pullback, the stock remains one of 2025’s standout industrial names, having delivered roughly 70–80% gains over the past year and trading within…
1 December 2025
···
Rigetti Computing (RGTI) Stock on December 1, 2025: Options Surge, Institutional Buying and a High‑Risk Quantum Roadmap

Rigetti Computing (RGTI) Stock on December 1, 2025: Options Surge, Institutional Buying and a High‑Risk Quantum Roadmap

Rigetti Computing, Inc. (NASDAQ: RGTI) remains one of 2025’s wildest quantum computing stories. On December 1, 2025, the RGTI stock price trades around the mid‑$20s, far below its recent peaks but still massively above where it began the year, as traders digest fresh options activity, new institutional positions, insider selling and a very ambitious quantum hardware roadmap. Yahoo Finance For…
1 December 2025
····
Cisco Stock on December 1, 2025: AI Momentum, Quantum Networking and Wall Street’s Latest CSCO Forecasts

Cisco Stock on December 1, 2025: AI Momentum, Quantum Networking and Wall Street’s Latest CSCO Forecasts

Published: December 1, 2025 – Information only, not investment advice. Snapshot: Where Cisco Stock Stands Today As of intraday trading on December 1, 2025, Cisco Systems, Inc. (NASDAQ: CSCO) is changing hands at around $76–77 per share, with a recent quote near $76.30 and an intraday range of roughly $76.04–$76.87. MarketBeat At this level: From a longer-term lens, Cisco’s 2025…
1 December 2025
···
Western Digital (WDC) Stock on December 1, 2025: AI Storage Star Faces ESOP Dilution, Spin-Off Legacy and Lofty Analyst Targets

Western Digital (WDC) Stock on December 1, 2025: AI Storage Star Faces ESOP Dilution, Spin-Off Legacy and Lofty Analyst Targets

Western Digital Corporation (NASDAQ: WDC) has turned into one of 2025’s standout AI infrastructure winners. As of the latest session on December 1, 2025, WDC trades around $163.54 per share, near record highs, capping a year in which the stock is up more than 200% year-to-date and has delivered roughly 197% total return over the past 12 months, making it…
1 December 2025
····
1 … 1,056 1,057 1,058 1,059 1,060 … 1,448

Stock Market Today

  • Floor & Decor shares around $76; DCF suggests overvaluation
    January 18, 2026, 5:44 AM EST. Floor & Decor Holdings trades near $76 a share after recent strength. The stock has risen 4.6% over the last week, 22.2% in the last month and 20.8% year-to-date, yet is down 23.8% over 12 months and 25% over five years. The retailer is described as a specialist hard-surface flooring supplier to both professional and DIY customers, a factor in how investors view housing-related names. Simply Wall St assigns a 0/6 valuation score. A two-stage DCF model puts an intrinsic value of about $24.37 per share, implying the current price is roughly 212% overvalued. The takeaway: the market prices in optimism not supported by the projected cash flows.
Go toTop